INDSWIFT LABORATORIES
Back to Income Statement
|
INDSWIFT LABORATORIES Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹421 Cr | ₹48 Cr | ₹-2.15 Cr | ₹-3.15 Cr | ₹-21 Cr |
What is the latest Consolidated Net Profit of INDSWIFT LABORATORIES ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹421 Cr |
| Mar2024 | ₹48 Cr |
| Mar2023 | ₹-2.15 Cr |
| Mar2022 | ₹-3.15 Cr |
| Mar2021 | ₹-21 Cr |
How is Consolidated Net Profit of INDSWIFT LABORATORIES Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹421 Cr | 784.43 | |
| Mar2024 | ₹48 Cr | Positive | |
| Mar2023 | ₹-2.15 Cr | Negative | |
| Mar2022 | ₹-3.15 Cr | Negative | |
| Mar2021 | ₹-21 Cr | - | |
Compare Consolidated Net Profit of peers of INDSWIFT LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDSWIFT LABORATORIES | ₹3,379.1 Cr | 5.8% | 63.8% | 257.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹451,339.0 Cr | -2.7% | -3.7% | 20.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹254,068.0 Cr | 3.7% | 15.7% | 51% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,767.0 Cr | -0.8% | 1% | 36.2% | Stock Analytics | |
| CIPLA | ₹111,804.0 Cr | -2.1% | -5.2% | -11.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,113.4 Cr | -0.8% | -0.5% | -9.3% | Stock Analytics | |
INDSWIFT LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDSWIFT LABORATORIES | 5.8% |
63.8% |
257.6% |
| SENSEX | -1.8% |
-3.7% |
-5.7% |
You may also like the below Video Courses